Inhibition of chemiluminescence in granulocytes and alveolar macrophages by azelastine
- 1 November 1990
- journal article
- research article
- Published by Springer Nature in Inflammation Research
- Vol. 31 (3-4) , 229-236
- https://doi.org/10.1007/bf01997613
Abstract
The effect of azelastine, an orally effective antiasthmatic/antiallergic drug, on the generation of oxygenderived free radicals in phagocytes was investigated using different chemiluminescence-assays. The chemiluminescence (CL) of both human polymorphonuclear granulocytes (PMNL) and guinea-pig alveolar macrophages (AM) was induced either by phorbol myristate acetate (PMA) or zymosan and amplified either by lucigenin or DMNH (7-dimethylamino-naphthalene-1,2-dicarbonic-acidhydrazide). The inhibitory effect of azelastine was dependent on the inducer employed and the condition and type of cells used. Azelastine reduced PMA-induced CL concentration-dependently in both PMNL (IC30=3.9 μM) and AM (IC30=9.8 μM). In AM zymosan-induced CL was inhibited 21.7% by 10 μM azelastine, whereas in PMNL it remained unchanged up to 10 μM azelastine. Azelastine has a significantly stronger inhibitory effect (IC30=4.2 μM) on oxygen free radical generation in AM primed by fetal calf serum than in unprimed AM. Based on present results it is likely that azelastine inhibitis oxygen-derived free radical generation by interaction with protein kinase C.Keywords
This publication has 30 references indexed in Scilit:
- The contribution of alveolar macrophages to hyperreactive airway diseaseJournal of Allergy and Clinical Immunology, 1989
- The O2−-forming NADPH oxidase of the phagocytes: nature, mechanisms of activation and functionBiochimica et Biophysica Acta (BBA) - Reviews on Bioenergetics, 1986
- The effect of single and multiple dose therapy with azelastine on the immediate asthmatic response to allergen provocation testingJournal of Allergy and Clinical Immunology, 1986
- Enhanced eosinophil luminol-dependent chemiluminescence in allergic rhinitisJournal of Allergy and Clinical Immunology, 1986
- DMNH — Ein neuer kompetenter Indikator für die Messung der Chemilumineszenz von neutrophilen Granulocyten und MonocytenJournal of Molecular Medicine, 1985
- 251 Azelastine (azel) in the treatment of asthmaJournal of Allergy and Clinical Immunology, 1985
- Leukocyte Activation in Allergen-Induced Late-Phase Asthmatic ReactionsNew England Journal of Medicine, 1984
- The respiratory burst of phagocytes.Journal of Clinical Investigation, 1984
- Phorbol 12-myristate 13-acetate activates rabbit neutrophils without an apparent rise in the level of intracellular free calciumBiochemical and Biophysical Research Communications, 1983
- Effect of Azelastine Hydrochloride on Macrophage Chemotaxis and Phagocytosis in VitroAllergy, 1982